Research of Exenatide for Overweight/Obese PCOS Patients With IGR
Status:
Completed
Trial end date:
2018-07-31
Target enrollment:
Participant gender:
Summary
Compare the therapeutic effects of exenatide, metformin and their combination for 3 months on
reproductive and metabolic improvements of overweight/obese PCOS patients with impaired
glucose regulation.